de Herder Wouter W
Department of Internal Medicine, Sector of Endocrinology, Erasmus MC, 3015 CE Rotterdam, The Netherlands.
Pituitary. 2009;12(3):236-44. doi: 10.1007/s11102-008-0138-y.
In 1886 Pierre Marie used the term "acromegaly" for the first time and gave a full description of the characteristic clinical picture. However several others had already given clear clinical descriptions before him and sometimes had given the disease other names. After 1886, it gradually became clear that pituitary enlargement (caused by a pituitary adenoma) was the cause and not the consequence of acromegaly, as initially thought. Pituitary adenomas could be found in the great majority of cases. It also became clear that acromegaly and gigantism were the same disease but occurring at different stages of life and not different diseases as initially thought. At the end of the 19th and beginning of the 20th century most information was derived from case descriptions and post-mortem examinations of patients with acromegaly or (famous) patients with gigantism. The stage was set for further research into the pathogenesis, diagnosis and therapy of acromegaly and gigantism.
1886年,皮埃尔·玛丽首次使用了“肢端肥大症”一词,并对其典型临床表现进行了全面描述。然而,在他之前已有其他人给出了清晰的临床描述,有时还给这种疾病起了其他名字。1886年之后,逐渐明确垂体肿大(由垂体腺瘤引起)是肢端肥大症的病因,而非如最初所认为的那样是其结果。绝大多数病例中都能发现垂体腺瘤。还明确了肢端肥大症和巨人症是同一种疾病,只是发生在生命的不同阶段,而非如最初所认为的是不同疾病。在19世纪末和20世纪初,大多数信息来自对肢端肥大症患者或(著名的)巨人症患者的病例描述和尸检。这为进一步研究肢端肥大症和巨人症的发病机制、诊断和治疗奠定了基础。